Literature DB >> 18792134

Speech intelligibility rating of cochlear implanted children: inter-rater reliability.

Andrew S Wilkinson1, Julie C Brinton.   

Abstract

The Speech Intelligibility Rating (SIR) scale was designed to classify children's global speech production according to one of five hierarchical categories. Individuals rating the scale need to judge which category is appropriate, giving the possibility that different raters could use different scores in their assessments. The aim of this study was to determine the inter-rater reliability of the scale, i.e. whether judges agree as to the category membership for the assessed behaviour. Inexperienced ('naive') judges rated videotape excerpts of implanted children in communication with a known adult according to the scale. Each judge rated four children sequentially from one of four videos: there were two videos of different sets of children, each recorded with two different orders. Both subsets of subjects ranked children in the same order of intelligibility (Kendall's W = 0.86 and W = 0.98 respectively, both p < 0.01). There was agreement on the category membership for each child (Kappa's K = 0.45 and K = 0.68 respectively, both p < 0.001). The intra-class correlation coefficient showed that agreement between raters was high (ICC(2,1) values = 0.80 and 0.81, both p < 0.001), and that ratings were consistent (ICC(3,1) values = 0.82 and 0.97, both p < 0.001). This study indicated that the scale demonstrates good inter-rater reliability. It can be used confidently by cochlear implant teams to monitor the progress of implanted children's speech intelligibility.

Entities:  

Year:  2003        PMID: 18792134     DOI: 10.1179/cim.2003.4.1.22

Source DB:  PubMed          Journal:  Cochlear Implants Int        ISSN: 1467-0100


  1 in total

1.  Validation and inter-rater reliability testing of the Arabic version of speech intelligibility rating among children with cochlear implant.

Authors:  Yazeed A Al-Shawi; Tamer A Mesallam; Nouf M Albakheet; Moath A Alshawi; Rayan M Alfallaj; Turki M Aldrees; Ashwag A Algahtani; Tahani O Alotaibi
Journal:  Saudi Med J       Date:  2020-10       Impact factor: 1.484

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.